Aclaris Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRS and other ETFs, options, and stocks.About ACRS
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments.
CEONeal S. Walker
CEONeal S. Walker
Employees64
Employees64
HeadquartersWayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded2012
Founded2012
Employees64
Employees64
ACRS Key Statistics
Market cap313.13M
Market cap313.13M
Price-Earnings ratio-2.08
Price-Earnings ratio-2.08
Dividend yield—
Dividend yield—
Average volume893.14K
Average volume893.14K
High today$3.10
High today$3.10
Low today$2.82
Low today$2.82
Open price$3.01
Open price$3.01
Volume1.29M
Volume1.29M
52 Week high$3.48
52 Week high$3.48
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
As of today, Aclaris Therapeutics(ACRS) shares are valued at $2.90. The company's market cap stands at 313.13M, with a P/E ratio of -2.08.
On 2026-01-04, Aclaris Therapeutics(ACRS) stock moved within a range of $2.82 to $3.10. With shares now at $2.90, the stock is trading +3.0% above its intraday low and -6.5% below the session's peak.
Trading activity shows a volume of 1.29M, compared to an average daily volume of 893.14K.
Over the past 52 weeks, Aclaris Therapeutics(ACRS) stock has traded between a high of $3.48 and a low of $1.05.
Over the past 52 weeks, Aclaris Therapeutics(ACRS) stock has traded between a high of $3.48 and a low of $1.05.
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own ACRS. This list is generated using Robinhood data, and it’s not a recommendation.